M&A M&A
HRV Pharma to acquire clinical trials-focused German co. Phatebo
Source Phatebo (opens in a new tab)Business Line (opens in a new tab)
Hyderabad-based HRV Pharma is to acquire 100% of the equity of Hilzingen, Germany-based Phatebo from ZeroStack.Founded in 2015, Phatebo, is a licensed pharmaceutical company that specializes in clinical trial supply and holds a German pharmaceutical wholesale authorisation. The company sources investigational, comparator, and ancillary medicines, including innovative branded therapies, for global pharma companies and clinical research organisations. It also trades in pharmaceuticals and medical devices across Europe and international markets, operating quality systems built for good distribution practice. In 2025, the firm recorded revenues of approximately INR 350 Cr.HRV Pharma (HRV Global Life Sciences) operates as an asset-light virtual pharma company that supplies a wide portfolio of active pharmaceutical ingredients (APIs), finished dosage forms (FDFs), and specialised medical products through a global network of cGMP-certified manufacturers.